Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-08-22
2006-08-22
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C544S264000, C544S317000, C558S085000, C261S004000
Reexamination Certificate
active
07094772
ABSTRACT:
The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
REFERENCES:
patent: 1944530 (1934-01-01), Schoönburg
patent: 5627185 (1997-05-01), Gosselin et al.
patent: 0 632 048 (1995-01-01), None
patent: 0 897 709 (1999-02-01), None
patent: 1280788 (1972-07-01), None
patent: 96/40088 (1996-12-01), None
patent: 99/08685 (1999-02-01), None
patent: 00/04032 (2000-01-01), None
Niemi et al., “Bisphosphonate Prodrugs: Synthesis and in Vitro Evaluation of Novel Acylox yalkyl Esters of Clodronic Acid,”J. Med. Chem., vol. 42, pp. 5053-5058 (1999).
Beadle James R.
Hostetler Karl Y.
Kini Ganesh D.
DLA Piper Rudnick Gray Cary US LLP
Solola Taofiq
The Regents of the University of California
LandOfFree
Phosphonate compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphonate compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphonate compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3705757